These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 17511372)

  • 1. The human papilloma virus, the vaccines, and oral and oropharyngeal squamous cell carcinoma: what every dentist should know.
    Closmann JJ
    Gen Dent; 2007; 55(3):252-4; quiz 255, 264. PubMed ID: 17511372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors in oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden.
    Rosenquist K
    Swed Dent J Suppl; 2005; (179):1-66. PubMed ID: 16335030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral HPV: the need for patient education.
    Merchant VA
    J Mich Dent Assoc; 2012 Mar; 94(3):16, 83. PubMed ID: 22662379
    [No Abstract]   [Full Text] [Related]  

  • 4. Vaccine may decrease chances of oral cancer.
    Br Dent J; 2007 Sep; 203(6):299. PubMed ID: 17891076
    [No Abstract]   [Full Text] [Related]  

  • 5. Oncogenic impact of human papilloma virus in head and neck cancer.
    Heffernan CB; O'Neill JP; Timon C
    J Laryngol Otol; 2010 Sep; 124(9):941-4. PubMed ID: 20519038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus vaccines.
    Satyaprakash A; Creed R; Ravanfar P; Mendoza N
    Dermatol Ther; 2009; 22(2):150-7. PubMed ID: 19335726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The GARDASIL vaccine can prevent cervical carcinoma caused by human papilloma virus (HPV) (results from our participation and from the study carried out in Greece).
    Ansstasiou-Fotaki P; Deligeoroglou E; Kreatsas G
    Akush Ginekol (Sofiia); 2007; 46(3):17-20. PubMed ID: 18018777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus (HPV) vaccines: limited cross-protection against additional HPV types.
    Herrero R
    J Infect Dis; 2009 Apr; 199(7):919-22. PubMed ID: 19236278
    [No Abstract]   [Full Text] [Related]  

  • 9. Quadrivalent human papillomavirus vaccine.
    Barr E; Tamms G
    Clin Infect Dis; 2007 Sep; 45(5):609-7. PubMed ID: 17682997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention strategies against the human papillomavirus: the effectiveness of vaccination.
    Stanley M
    Gynecol Oncol; 2007 Nov; 107(2 Suppl 1):S19-23. PubMed ID: 17938013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical cancer prevention in the human papilloma virus vaccine era.
    Ghazal-Aswad S
    Ann N Y Acad Sci; 2008 Sep; 1138():253-6. PubMed ID: 18837904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Squamous cell carcinoma of the oropharynx in Australian males induced by human papillomavirus vaccine targets.
    Hong AM; Grulich AE; Jones D; Lee CS; Garland SM; Dobbins TA; Clark JR; Harnett GB; Milross CG; O'Brien CJ; Rose BR
    Vaccine; 2010 Apr; 28(19):3269-72. PubMed ID: 20226244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years.
    Brown DR; Kjaer SK; Sigurdsson K; Iversen OE; Hernandez-Avila M; Wheeler CM; Perez G; Koutsky LA; Tay EH; Garcia P; Ault KA; Garland SM; Leodolter S; Olsson SE; Tang GW; Ferris DG; Paavonen J; Steben M; Bosch FX; Dillner J; Joura EA; Kurman RJ; Majewski S; Muñoz N; Myers ER; Villa LL; Taddeo FJ; Roberts C; Tadesse A; Bryan J; Lupinacci LC; Giacoletti KE; Sings HL; James M; Hesley TM; Barr E
    J Infect Dis; 2009 Apr; 199(7):926-35. PubMed ID: 19236279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chapter 16: HPV vaccines in immunocompromised women and men.
    Palefsky JM; Gillison ML; Strickler HD
    Vaccine; 2006 Aug; 24 Suppl 3():S3/140-6. PubMed ID: 16950001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan.
    Tay SK; Ngan HY; Chu TY; Cheung AN; Tay EH
    Vaccine; 2008 Aug; 26 Suppl 12():M60-70. PubMed ID: 18945415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Human papilloma virus infection and cervical cancer: a public health perspective].
    Torres-Poveda KJ; Burguete A; Bermúdez-Morales VH; Madrid-Marina V
    Rev Invest Clin; 2008; 60(5):414-20. PubMed ID: 19227439
    [No Abstract]   [Full Text] [Related]  

  • 17. Cost-utility analysis of vaccination against HPV in Israel.
    Ginsberg GM; Fisher M; Ben-Shahar I; Bornstein J
    Vaccine; 2007 Sep; 25(37-38):6677-91. PubMed ID: 17706844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPV-linked oral cancer: another argument for universal HPV vaccination of boys and girls.
    Laurence J
    AIDS Read; 2008 Jul; 18(7):345-6. PubMed ID: 18655309
    [No Abstract]   [Full Text] [Related]  

  • 19. Recurrence in patients with oral and oropharyngeal squamous cell carcinoma: human papillomavirus and other risk factors.
    Rosenquist K; Wennerberg J; Annertz K; Schildt EB; Hansson BG; Bladström A; Andersson G
    Acta Otolaryngol; 2007 Sep; 127(9):980-7. PubMed ID: 17712679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing patient risk for human papillomavirus infection and cervical cancer.
    Herbert J; Coffin J
    J Am Osteopath Assoc; 2008 Feb; 108(2):65-70. PubMed ID: 18303060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.